Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D. F.; Ernstoff, M.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A. R. A.; Kollmannsberger, C. K.; Heng, D. Y. C.; Spratlin, J. L.; Shen, Y.; Gagnier, P.; Amin, A.
Abstract Title: Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036900984
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.4516
Notes: Meeting Abstract: 4516 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Henner Voss
    288 Voss